Mining Stored-Specimen Studies for Information about Cancer Natural History
- 1 September 2026
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 35 (9) , 1484-1486
Abstract
The advent of new multicancer early detection tests and publication of early diagnostic results have generated expectations of clinical benefit from multicancer screening. The clinical benefit of a cancer screening test depends critically on disease natural history, which is typically learned from prospective screening studies. Retrospective studies of stored blood specimens are important in learning about a test’s preclinical diagnostic performance but have rarely been used to infer natural history. The extent to which these studies might be harnessed to also learn natural history is discussed in the context of an article in this issue that infers the combined natural history of a range of cancers targeted by a multicancer early detection test using a case–control subsample of specimens from a large cohort study. The critical question concerns the identifiability of key transition rates in multistate models of natural history alongside state-specific sensitivities. The article suggests that these parameters are estimable within a Bayesian framework that leverages prior information about test sensitivity from diagnostic studies. We offer a heuristic discussion of identifiability in this setting and encourage formal study to determine the extent to which models with varying degrees of complexity may be learned from stored-specimen studies. See related article by Dai et al., p. 1535Keywords
This publication has 15 references indexed in Scilit:
- Designing cancer screening trials for reduction in late-stage cancer incidenceBiometrics, 2024
- Multistate models for the natural history of cancer progressionBritish Journal of Cancer, 2022
- Identification of the Fraction of Indolent Tumors and Associated Overdiagnosis in Breast Cancer Screening TrialsAmerican Journal of Epidemiology, 2018
- A Bayesian model for estimating multi-state disease progressionComputers in Biology and Medicine, 2017
- A Systematic Approach to Determining the Identifiability of Multistage Carcinogenesis ModelsRisk Analysis, 2016
- Structural and practical identifiability analysis of partially observed dynamical models by exploiting the profile likelihoodBioinformatics, 2009
- An Early‐ and Late‐Stage Convolution Model for Disease Natural HistoryBiometrics, 2004
- Phases of Biomarker Development for Early Detection of CancerJNCI: Journal of the National Cancer Institute, 2001
- Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phaseStatistics in Medicine, 1995
- On the theory of screening for chronic diseasesBiometrika, 1969